As of Jul 21
| -0.70 / -1.34%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 72.00, with a high estimate of 72.00 and a low estimate of 72.00. The median estimate represents a +40.21% increase from the last price of 51.35.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.